← Eichor
Study identifier: NCT07230509 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate

Condition: Pancreaticoduodenectomy · Postoperative Pancreatic Fistula · Pancreas Cancer  ·  Sponsor: Minia University

PhasePhase 2
Planned participants90
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This randomized controlled trial investigates the safety and efficacy of injecting N-butyl-2- cyanoacrylate (Histoacryl®) into the pancreatic parenchyma during pancreaticoduodenectomy (PD) to enhance the security of the pancreaticojejunostomy (PJ) anastomosis and reduce postoperative pancreatic fistula (POPF) rates.

This description comes directly from the study's public registry record.

Talk to the study team

Saleh K Saleh, MD  ·  01201765401  ·  salehkhairy@mu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Liver and GIT hospital , Minia UniversityMinya, Minya Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07230509